Martinez-Cajas JL - Search Results

1

Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis.

Pant Pai N, Balram B, Shivkumar S, Martinez-Cajas JL, Claessens C, Lambert G, Peeling RW, Joseph L. Pant Pai N, et al. Lancet Infect Dis. 2012 May;12(5):373-80. doi: 10.1016/S1473-3099(11)70368-1. Epub 2012 Jan 24. Lancet Infect Dis. 2012. PMID: 22277215 Review.

2

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.

Martínez-Cajas JL, Pant-Pai N, Klein MB, Wainberg MA. Martínez-Cajas JL, et al. AIDS Rev. 2008 Oct-Dec;10(4):212-23. AIDS Rev. 2008. PMID: 19092977 Review.

3

Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).

Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA. Martinez-Cajas JL, et al. J Int AIDS Soc. 2009 Jun 30;12:11. doi: 10.1186/1758-2652-12-11. J Int AIDS Soc. 2009. PMID: 19566959 Free PMC article.

4

Protease inhibitor resistance in HIV-infected patients: molecular and clinical perspectives.

Martinez-Cajas JL, Wainberg MA. Martinez-Cajas JL, et al. Antiviral Res. 2007 Dec;76(3):203-21. doi: 10.1016/j.antiviral.2007.06.010. Epub 2007 Jul 16. Antiviral Res. 2007. PMID: 17673305 Review.

5

Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease.

Wainberg MA, Martinez-Cajas JL. Wainberg MA, et al. Infect Disord Drug Targets. 2009 Apr;9(2):172-90. doi: 10.2174/187152609787847668. Infect Disord Drug Targets. 2009. PMID: 19275705 Review.

6

In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibitor.

Asahchop EL, Oliveira M, Quashie PK, Moisi D, Martinez-Cajas JL, Brenner BG, Tremblay CL, Wainberg MA. Asahchop EL, et al. Among authors: martinez cajas jl. J Antimicrob Chemother. 2013 Jan;68(1):105-12. doi: 10.1093/jac/dks342. Epub 2012 Sep 3. J Antimicrob Chemother. 2013. PMID: 22945918

7

Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.

Martinez-Cajas JL, Wainberg MA. Martinez-Cajas JL, et al. Drugs. 2008;68(1):43-72. doi: 10.2165/00003495-200868010-00004. Drugs. 2008. PMID: 18081372 Review.

8

HIV-1 protease codon 36 polymorphisms and differential development of resistance to nelfinavir, lopinavir, and atazanavir in different HIV-1 subtypes.

Lisovsky I, Schader SM, Martinez-Cajas JL, Oliveira M, Moisi D, Wainberg MA. Lisovsky I, et al. Antimicrob Agents Chemother. 2010 Jul;54(7):2878-85. doi: 10.1128/AAC.01828-09. Epub 2010 Apr 19. Antimicrob Agents Chemother. 2010. PMID: 20404123 Free PMC article.

9

The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.

Martinez-Cajas JL, Wainberg MA, Oliveira M, Asahchop EL, Doualla-Bell F, Lisovsky I, Moisi D, Mendelson E, Grossman Z, Brenner BG. Martinez-Cajas JL, et al. J Antimicrob Chemother. 2012 Apr;67(4):988-94. doi: 10.1093/jac/dkr582. Epub 2012 Feb 7. J Antimicrob Chemother. 2012. PMID: 22315096

10

Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes.

Asahchop EL, Oliveira M, Brenner BG, Martinez-Cajas JL, Toni Td, Ntemgwa M, Moisi D, Dandache S, Stranix B, Tremblay CL, Wainberg MA. Asahchop EL, et al. Antiviral Res. 2010 Sep;87(3):367-72. doi: 10.1016/j.antiviral.2010.06.001. Epub 2010 Jun 10. Antiviral Res. 2010. PMID: 20541566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters